Qualigen
     

 
 
History
 
  1937     Foundation of Laboratorios Vita, S.A.
  1961     Vita directs its activity to the prescription pharmaceutical market.
  1979     Purchase of Laboratorios Lesvi, S.A.
  1980     Foundation of the chemical plant INKE, S.A.
  1995     Joint-venture with BAYER
  1998     Beginning of international expansion
  2002     Ending of BAYER joint-venture
  2004     Purchase of Vita by Procter&Gamble
  2005     Purchase of Laboratorios LESVI, S.L. and the chemical plant INKE, S.A. by Invent Farma (Iceland)
  2006     Foundation of Qualigen, S.L.
  2006     Foundation of Laboratorios DOMAC, S.L. (Joint Venture between Invent Farma, S.L. and Strides Arcolab, LTD)
  2007     Purchase of 75% of Lyfjaver
  2007     Purchase of 50% of Farmaplus

Since its present our vertically integrated company group (LESVI-INKE) has undergone a steadly growth to become today among Spain’s top Pharmaceutical companies. LESVI-INKE uses mainly its own environmentally respectful technology for all of its integrated activities, from the manufacture of active ingredients, to in-house R&D and the production and sale of ethical pharmaceutical products.
 
Our highly skilled, dedicated and motivated 300 employees team with their commitment to the service of the Health Care industry make our Mission come true. It is the dedication and enthusiasm of our employees that makes LESVI-INKE group a solid undertaking today with a great future lying ahead.
 
 
 
 
© All rights reserved. Invent Farma Group.